EUVIMEDEUVIMED entdecken
Open Access

Prevalence and Clinical Characteristics of Heterozygous RNF213 p.Arg4810Lys Variant Carriers Diagnosed With Chronic Thromboembolic Pulmonary Hypertension

Takatoyo Kiko, Ryotaro Asano iD, Tomohiko Ishibashi iD, Hiroyuki Endo iD, Naruhiro Nishi iD, Hiroya Hayashi iD, Jin Ueda iD, Tatsuo Aoki iD, Akihiro Tsuji iD, Yoshikazu Nakaoka iD, Takeshi Ogo iD

Journal of the American Heart Association · 2024

DOI: 10.1161/jaha.124.035009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Takatoyo Kiko und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary Circulation, Department of Cardiovascular Medicine National Cerebral and Cardiovascular Center Osaka Japan. Hauptthemen laut MEDLINE: Pulmonary Embolism, Heterozygote, Hypertension, Pulmonary, Adenosine Triphosphatases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ring finger protein 213 ( RNF213 ) p.Arg4810Lys is a susceptibility gene for moyamoya disease, peripheral pulmonary artery stenosis (PPS), and other vascular diseases and thrombosis. We investigated the prevalence and clinical characteristics of RNF213 variant carriers diagnosed with chronic thromboembolic pulmonary hypertension (CTEPH). Methods and Results We retrospectively analyzed the prevalence of the RNF213 p.Arg4810Lys variant in patients diagnosed with CTEPH (n=112) and PPS (n=10). Clinical and angiographic characteristics were evaluated between RNF213 variant carriers diagnosed with CTEPH and noncarriers with CTEPH and homozygous variant carriers with PPS. Eight heterozygous RNF213 p.Arg4810Lys variant carriers (7.1%) were identified among patients diagnosed with CTEPH, while 5 patients with PPS (50%) carried the homozygous variant. The clinical characteristics of heterozygous variant carriers with CTEPH were not remarkably different from those of noncarriers with CTEPH. All heterozygous variant carriers with CTEPH showed webs/bands lesions at the segmental/subsegmental level, with 75% showing distal tortuous vessels. None of the heterozygous variant carriers with CTEPH exhibited the string‐of‐beads pattern or elongated stenosis. Homozygous variant carriers with PPS showed the string‐of‐beads pattern, elongated stenosis, and distal tortuous vessels without webs/bands lesions.

Conclusions

A subset of patients diagnosed with CTEPH (7.1%) carried the heterozygous RNF213 p.Arg4810Lys variant. Clinical and angiographic characteristics of heterozygous variant carriers were not remarkably different from those of noncarriers of CTEPH. However, both heterozygous variant carriers with CTEPH and homozygous variant carriers with PPS showed tortuous vessels on angiography.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary EmbolismHeterozygoteHypertension, PulmonaryAdenosine TriphosphatasesUbiquitin-Protein LigasesGenetic Predisposition to DiseaseHumansMaleFemaleMiddle AgedRetrospective StudiesPrevalenceChronic DiseaseAgedAdultPulmonary ArteryStenosis, Pulmonary ArteryMutation

Stichwörter der Autor:innen

RNF213chronic thromboembolic pulmonary hypertensionperipheral pulmonary artery stenosis

Substanzen

RNF213 protein, humanAdenosine TriphosphatasesUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • Division of Pulmonary Circulation, Department of Cardiovascular Medicine National Cerebral and Cardiovascular Center Osaka Japan.
  • Department of Vascular Physiology National Cerebral and Cardiovascular Center Research Institute Osaka Japan.

ORCID-Profile: Ryotaro Asano, Tomohiko Ishibashi, Hiroyuki Endo, Naruhiro Nishi, Hiroya Hayashi, Jin Ueda, Tatsuo Aoki, Akihiro Tsuji, Yoshikazu Nakaoka, Takeshi Ogo

Zitieren

APA

Kiko, T., Asano, R., Ishibashi, T., Endo, H., Nishi, N., Hayashi, H., Ueda, J., Aoki, T., Tsuji, A., Nakaoka, Y., & Ogo, T. (2024). Prevalence and Clinical Characteristics of Heterozygous RNF213 p.Arg4810Lys Variant Carriers Diagnosed With Chronic Thromboembolic Pulmonary Hypertension. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.035009

Vancouver

Kiko T, Asano R, Ishibashi T, Endo H, Nishi N, Hayashi H, et al. Prevalence and Clinical Characteristics of Heterozygous RNF213 p.Arg4810Lys Variant Carriers Diagnosed With Chronic Thromboembolic Pulmonary Hypertension. Journal of the American Heart Association. 2024. doi:10.1161/jaha.124.035009

BibTeX
@article{Kiko2024,
  author = {Kiko, Takatoyo and Asano, Ryotaro and Ishibashi, Tomohiko and Endo, Hiroyuki and Nishi, Naruhiro and Hayashi, Hiroya and Ueda, Jin and Aoki, Tatsuo and Tsuji, Akihiro and Nakaoka, Yoshikazu and Ogo, Takeshi},
  title = {Prevalence and Clinical Characteristics of Heterozygous RNF213 p.Arg4810Lys Variant Carriers Diagnosed With Chronic Thromboembolic Pulmonary Hypertension},
  journal = {Journal of the American Heart Association},
  year = {2024},
  doi = {10.1161/jaha.124.035009}
}
Kostenlos starten →